The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells

• Published in: Biochemical and biophysical research communications 2012-06, Vol.423 (1), p.188-194
• Main Authors: Kang, Hyereen, Ko, Jesang, Jang, Sung-Wuk
• Format: Article
• Language: English
• Subjects: 60 APPLIED LIFE SCIENCES; ABLATION; Annexin A1; Annexin A1 - genetics; Annexin A1 - metabolism; BIOLOGICAL EFFECTS; Breast cancer; Breast Neoplasms - enzymology; Breast Neoplasms - pathology; Cell invasion; Cell Line, Tumor; DNA - metabolism; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HORMONES; Humans; INHIBITION; MAMMARY GLANDS; Matrix Metalloproteinase 9 - genetics; MESSENGER-RNA; MMP-9; Neoplasm Invasiveness; NEOPLASMS; NF-kappa B - metabolism; NF-κB; Promoter Regions, Genetic; PROTEINS; RNA, Small Interfering - genetics
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2012.05.114

► We evaluated the effect of ANXA1 on promoting migration and invasion in MDA-MB-231 cells. ► ANXA1 siRNA inhibits invasion and migration. ► ANXA1 regulates MMP-9 expression and activity. ► ANX-1 siRNA inhibits the activation of NF-κB in MDA-MB-231 cells. Matrix metalloproteinase-9 (MMP-9) plays an important role in the invasion and metastasis of cancer cells. However, the regulatory mechanism of MMP-9 expression and its biological effects on breast cancer development remain obscure. In the current study, we examined the potential role of annexin A1 (ANXA1) in regulating migration and invasion in breast cancer cell lines. Both ANXA1 mRNA and protein are expressed in the highly invasive, hormone-insensitive human breast cancer cell lines MDA-MB-231 and SKBr3, but not in the hormone-responsive cell lines MCF-7 and T47D. Downregulation of ANXA1 expression with specific small interfering RNAs (ANXA1 siRNA) in MDA-MB-231 cells resulted in decreased cancer cell migration and invasion. Ablation of ANXA1 expression decreases the expression of MMP-9 at both the mRNA and protein levels and also reduces the proteolytic activity of MMP-9 in MDA-MB-231 cells. Moreover, silencing ANXA1 also decreases the transcriptional activity of MMP-9 by the suppression of nuclear factor kappa-B (NF-κB) activity. Collectively, these results indicate that ANXA1 functions as a positive regulator of MMP-9 expression and invasion of breast cancer cells through specific activation of the NF-κB signaling pathway.